Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Abdominal Cancer × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 Pain 11 Colorectal Neoplasms 11 Neoplasms 10 Pain, Postoperative 9 Prostatic Neoplasms 7 Lung Neoplasms 6 Agnosia 5 Neuralgia 4 Keratosis, Actinic 4 Colonic Neoplasms 4 Cancer Pain 4 Liver Neoplasms 3 Head and Neck Neoplasms 3 Chronic Pain 3 Stomach Neoplasms 2 Pilonidal Sinus 2 Oropharyngeal Neoplasms 2 Myofibroma 2 Leiomyoma 2 Ileus 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunction, Physiological 1 Recurrent Laryngeal Nerve Injuries 1 Recurrence 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Supine Position 1 Morphine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Head-Down Tilt 1 Ethanol 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063112 2017-02-28

RF

South Egypt Cancer Institute

Phase NA Unknown

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡